InnoCare Pharma Limited

HKEX:9969.HK

5.85 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 8,201.8398,224.5968,261.5468,367.0678,543.3038,697.9278,668.0515,961.245-6,245.7755,928.7166,254.8116,254.8113,969.643,969.644,409.8234,409.8232,291.7732,349.9922,255.3942,255.3941,876.618
Short Term Investments 0-00321.580313.290246.2412,491.55317.059000030.13730.13780.34790.392107.544107.544169.054
Cash and Short Term Investments 8,201.8398,224.5968,261.5468,688.6478,543.3039,011.2178,668.0516,207.4856,245.7756,245.7756,254.8116,254.8113,969.643,969.644,439.964,439.962,372.122,440.3842,362.9382,362.9382,045.672
Net Receivables 232.959276.378184.115209.268150.635-102.269127.437164.6020145.07822.81822.818120.6750.1520.0580.0580.0370.0270.0690.0690.044
Inventory 118.158119.095116.911109.48398.91565.32248.19520.27709.9186.746.741.8781.878-30.137-30.137-80.347-90.392-107.544-107.544-169.054
Other Current Assets 14.48582.715336.05552.201382.638325.438320.47722.084016.34142.387119.5690.04120.56361.57391.65236.62738.649136.82136.8217.832
Total Current Assets 8,620.7148,765.3238,945.4979,111.4129,175.4919,299.7089,164.1616,414.4486,245.7756,417.1116,403.9386,403.9384,092.2334,092.2334,501.5334,501.5332,408.7472,479.0332,392.2832,392.2832,063.504
Non-Current Assets:
Property, Plant & Equipment, Net 823.4361,089.039751.504995.087696.525952.213596.999792.0340502.366523.218523.218329.353403.131243.704243.70458.424103.31718.31318.31317.961
Goodwill 3.1253.1253.1253.1253.1253.1253.1253.12503.1253.1253.1253.1253.1253.1253.1253.1253.1253.1253.1253.125
Intangible Assets 263.49639.007266.03638.636270.6141.305263.98332.0070139.44636.27836.278111.8437.01736.93636.936113.37736.83577.46277.462114.084
Goodwill and Intangible Assets 266.62142.132269.1641.761273.73544.43267.10835.1320142.57139.40339.403114.96540.14240.06140.061116.50239.9680.58780.587117.209
Long Term Investments 4.3215.668.185-311.95511.003-301.57812.14577.74409.0392.0142.0141.1591.159-28.9781.159-79.188-89.2331.1591.159-167.895
Tax Assets 31.399.77636.255321.580301.578000275.493-2.0140-1.159030.137080.34790.39200169.054
Other Non-Current Assets 19.8027.19929.0232.83159.16124.807390.869321.408-6,245.77550.95115.74713.7331.1591.04518.10418.10430.86132.45242.57642.5761.326
Total Non-Current Assets 1,145.571,153.8061,094.1251,079.3041,040.4231,021.451,267.1211,226.318-6,245.775980.42578.368578.368445.477445.477303.028303.028206.946176.888142.635142.635137.655
Total Assets 9,766.2839,919.12910,039.62210,190.71610,215.91410,321.15810,431.2827,640.76607,397.5316,982.3066,982.3064,537.714,537.714,804.5614,804.5612,615.6932,655.9212,534.9182,534.9182,201.159
Liabilities & Equity:
Current Liabilities:
Account Payables 118.709134.905113.913129.429148.943118.59799.57592.024084.60214.73914.7395.525.529.5329.5328.1975.8873.0733.0732.193
Short Term Debt 30.531,279.36451,245.29901,217.28017.482020.33619.93506.83305.506015.30215.8728.9418.94164.609
Tax Payables 27.32415.25323.8840032.58020.606037.36001.4010000.5290.508000.575
Deferred Revenue -30.53203.389177.190000000001.4010000.5290.508000.575
Other Current Liabilities 1,936.639476.3361,727.177698.4511,887.371739.551702.959194.8330224.364108.825128.7690.69998.93351.15556.66141.64416.2958.8278.8274.912
Total Current Liabilities 2,055.3482,093.9942,023.282,073.1792,036.3142,075.428802.535304.3390329.302143.499143.499104.453104.45366.19366.19365.67238.56220.84120.84172.289
Non-Current Liabilities:
Long Term Debt 68.76469.94748.29642.865321.79235.439321.1681,260.06601,248.0061,228.4241,228.4241,166.7151,166.7151,150.5171,150.5171,120.571,005.5333,572.3783,572.378965.06
Deferred Revenue Non-Current 277.903268.906287.099275.6910278.2030277.0860123.61110001000154.920157.389157.5260061.398
Deferred Tax Liabilities Non-Current 32.29623.79713.87600000005.73406.03606.03606.0366.036006.036
Other Non-Current Liabilities 277.903281.78287.099296.451289.488287.7611,525.548279.182037.6930105.7340106.0360160.9564,213.7722,925.22472.48272.4821,934.75
Total Non-Current Liabilities 656.866644.43636.37615.007611.279601.4031,846.7161,816.33401,409.311,334.1581,334.1581,272.7511,272.7511,311.4731,311.4735,497.7674,094.3193,644.863,644.862,967.244
Total Liabilities 2,712.2142,738.4242,659.6512,688.1862,647.5932,676.8312,649.2512,120.67301,738.6121,477.6571,477.6571,377.2041,377.2041,377.6661,377.6665,563.4394,132.8813,665.7013,665.7013,039.533
Equity:
Preferred Stock 0000036.3120003,767.1863,894.31503,639.2403,247.28403,080.3951,590.92400939.007
Common Stock 0.0230.0230.0230.0230.0230.0230.0230.01900.0190.0190.0190.0160.0160.0160.0160.0040.0040.0030.0030.003
Retained Earnings -5,221.924-5,054.191-4,979.423-4,845.139-4,460.664-4,422.928-4,395.815-3,977.6780-3,536.335-3,681.206-3,681.206-3,544.188-3,544.188-3,487.578-3,487.578-3,080.395-1,590.924-1,260.313-1,260.313-939.007
Accumulated Other Comprehensive Income/Loss 12,253.75677.23212,322.685197.37911,983.559-36.31297.40937.2395,604.559-230.851-213.109-213.109-95.052-95.052240.294240.294-3.447-3.06564.15464.154-1.985
Other Total Stockholders Equity -7.38612,124.784-2.41712,110.014012,020.00612,034.5579,410.62254.365,604.545,451.89,346.1153,103.9966,743.2363,372.5746,619.858-3,001.267-1,538.50300-902.319
Total Shareholders Equity 7,024.4697,147.8487,340.8677,462.2777,522.9187,597.1017,736.1735,470.2025,658.9195,604.5595,451.8195,451.8193,104.0123,104.0123,372.593,372.59-3,004.71-1,541.564-1,196.156-1,196.156-904.301
Total Equity 7,054.0697,180.7057,379.9717,502.537,568.3217,644.3277,782.0315,520.0935,658.9195,658.9195,504.6495,504.6493,160.5063,160.5063,426.8953,426.895-2,947.746-1,476.96-1,130.783-1,130.783-838.374
Total Liabilities & Shareholders Equity 9,766.2839,919.12910,039.62210,190.71610,215.91410,321.15810,431.2827,640.7665,658.9197,397.5316,982.3066,982.3064,537.714,537.714,804.5614,804.5612,615.6932,655.9212,534.9182,534.9182,201.159